2019
DOI: 10.1093/carcin/bgz080
|View full text |Cite
|
Sign up to set email alerts
|

Autophagy inhibition as a promising therapeutic target for laryngeal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
31
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(35 citation statements)
references
References 40 publications
4
31
0
Order By: Relevance
“…Of interest is that some of these markers had prognostic value when correlated with clinical variables (Figure 4). Besides, we suggested that the acquisition of resistance to cisplatin is related to the development of 5-fluorouracil resistance, supporting the presence of a common regulatory resistance pathway (187).…”
Section: Autophagy and Cancer Cell Resistancementioning
confidence: 55%
“…Of interest is that some of these markers had prognostic value when correlated with clinical variables (Figure 4). Besides, we suggested that the acquisition of resistance to cisplatin is related to the development of 5-fluorouracil resistance, supporting the presence of a common regulatory resistance pathway (187).…”
Section: Autophagy and Cancer Cell Resistancementioning
confidence: 55%
“…A stressful extracellular microenvironment, such as hypoxia or low glucose, may upregulate GLUT-1 expression [37]. Indeed, hypoxia promotes the proliferation, migration, and chemoresistance of CSCs [4][5][6][7]14,15]. In this study, the growth and migration of CD133 + Tu212 cells were greater than those of CD133 -Tu212 cells under hypoxic and low-glucose conditions; this was associated with increased mRNA and protein levels of GLUT-1 in CD133 + Tu212 cells.…”
Section: Discussionmentioning
confidence: 68%
“…CSCs are closely related to the occurrence, development, metastasis, recurrence, and chemoradiotherapy resistance of tumors [4]. Laryngeal CSCs reportedly express CD133 as a marker [5]. CD133 + CSCs have higher tumorigenic and invasive abilities than CD133cancer cells [5][6][7]10].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…CSCs are closely related to the occurrence, development, metastasis, recurrence, and chemoradiotherapy resistance of tumors [4]. Laryngeal CSCs reportedly express CD133 as a marker [5]. CD133 + CSCs have higher tumorigenic and invasive abilities than CD133 − cancer cells [5][6][7]10].…”
Section: Introductionmentioning
confidence: 99%